1-5 of 5
Authors: Arangassery Rosemary Bastian
Journal Article
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial Open Access
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages e374–e383, https://doi.org/10.1093/infdis/jiad594
Published: 22 December 2023
Journal Article
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study Open Access
The Journal of Infectious Diseases, Volume 229, Issue 1, 15 January 2024, Pages 19–29, https://doi.org/10.1093/infdis/jiad220
Published: 11 July 2023
Journal Article
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months Open Access
The Journal of Infectious Diseases, Volume 227, Issue 1, 1 January 2023, Pages 71–82, https://doi.org/10.1093/infdis/jiac407
Published: 19 October 2022
Journal Article
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study Open Access
The Journal of Infectious Diseases, Volume 226, Issue 3, 1 August 2022, Pages 396–406, https://doi.org/10.1093/infdis/jiab003
Published: 05 January 2021
Journal Article
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years Free
The Journal of Infectious Diseases, Volume 222, Issue 6, 15 September 2020, Pages 979–988, https://doi.org/10.1093/infdis/jiaa193
Published: 22 April 2020
